These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3940735)

  • 21. One-step, labeled-antibody assay for measuring free thyroxin. II. Performance in a multicenter trial.
    Sheehan CP; Christofides ND
    Clin Chem; 1992 Jan; 38(1):19-25. PubMed ID: 1733602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-analyte immunoassay.
    Ekins RP
    J Pharm Biomed Anal; 1989; 7(2):155-68. PubMed ID: 2488616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable underestimates by serum free thyroxine (T4) immunoassays of free T4 concentrations in simple solutions.
    Nelson JC; Nayak SS; Wilcox RB
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1373-5. PubMed ID: 7962331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Labelled antibody-based one-step time-resolved fluoroimmunoassay for measurement of free thyroxine in serum.
    Wang Z; Lao HM; Liu T; Li LQ; Li M; Wu YS
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):550-7. PubMed ID: 21885471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors interfering with and influencing the measurement of direct and indirect parameters of free thyroxine].
    Reiners C
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1292-9. PubMed ID: 3527642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of labeled thyroxin analog to serum proteins evaluated after radioimmunoassay of free thyroxin.
    Arevalo G
    Clin Chem; 1989 Mar; 35(3):475-7. PubMed ID: 2465846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of analog free thyroxin immunoassays. Part II.
    Midgley JE; Moon CR; Wilkins TA
    Clin Chem; 1987 Dec; 33(12):2145-52. PubMed ID: 3121213
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new one-step, labeled-antibody assay for measuring free thyroid hormone concentrations].
    Kasagi K; Kousaka T; Misaki T; Miyamoto S; Takeuchi R; Konishi J
    Kaku Igaku; 1994 Dec; 31(12):1525-37. PubMed ID: 7861652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A direct free thyroxine (T4) immunoassay with the characteristics of a total T4 immunoassay.
    Fritz KS; Wilcox RB; Nelson JC
    Clin Chem; 2007 May; 53(5):911-5. PubMed ID: 17363415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Measurement of serum free thyroxine concentrations using anti-T4 monoclonal antibody].
    Ikekubo K; Saiki Y; Ohta K; Ishikawa M; Yamaguchi H; Ito H; Hino M; Hattori N; Ishihara T; Moridera K
    Kaku Igaku; 1994 Apr; 31(4):379-92. PubMed ID: 8196235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical theory of complex ligand-binding systems applied to free triiodothyronine immunoassays.
    Blomberg KR; Engblom SO
    Anal Chem; 1991 Nov; 63(22):2581-6. PubMed ID: 1776697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme immunoassay for free thyroxin.
    Weetall HH; Hertl W; Ward FB; Hersh LS
    Clin Chem; 1982 Apr; 28(4 Pt 1):666-71. PubMed ID: 6804116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The biotin-thyroxin conjugate as a bifunctional ligand of binding proteins].
    Novakovskiĭ ME; Vashkevich II; Sviridov OV
    Bioorg Khim; 2009; 35(2):178-91. PubMed ID: 19537169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biases in antibody-based single-phase assays for free thyroxine due to protein-bound analyte.
    Tanhehco YC; Peck Palmer OM; Derrico LS; Sepulveda JL; Blair HC
    Clin Chim Acta; 2009 Aug; 406(1-2):176-8. PubMed ID: 19500559
    [No Abstract]   [Full Text] [Related]  

  • 35. Multilayer fluorescent immunoassay technique.
    Grenner G; Inbar S; Meneghini FA; Long EW; Yamartino EJ; Bowen MS; Blackwood JJ; Padilla AJ; Maretsky D; Staedter M
    Clin Chem; 1989 Sep; 35(9):1865-8. PubMed ID: 2776310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of albumin concentration on the assay of serum free thyroxin by equilibrium radioimmunoassay with labeled thyroxin analog (Amerlex Free T4).
    Amino N; Nishi K; Nakatani K; Mizuta H; Ichihara K; Tanizawa O; Miyai K
    Clin Chem; 1983 Feb; 29(2):321-5. PubMed ID: 6401605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-isotopic, two-step free thyroxine immunoassay: a better measure of free thyroxine than analogue radioimmunoassay.
    Beckett GJ; Ratcliffe WA; Chapman B; Wu P; Rae PW; Gow SM; Toft AD
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():581-91. PubMed ID: 2127878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects and clinical significance of exogenous thyroxine therapy in patients with circulating thyroid hormone autoantibodies.
    Premachandra BN; Walfish PG
    Am J Clin Pathol; 1982 Jul; 78(1):63-8. PubMed ID: 7102608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Model analysis of bidirectional interference in two-stage labeled-ligand immunoassays.
    Lewin ER; Dasgupta A; Valdes R; Stickle DF
    Clin Biochem; 2017 Dec; 50(18):1188-1197. PubMed ID: 28803963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of protein binding abnormalities in euthyroid hyperthyroxinemia.
    George PM; Sheat JM; Palmer BN
    Clin Chem; 1988 Sep; 34(9):1745-8. PubMed ID: 3416422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.